Crohn's Disease

Intermittent fasting during the month of Ramadan was associated with deterioration of clinical parameters in a small group of patients with ulcerative colitis, according to research published in BMC Gastroenterology.

Individuals who have a sibling with inflammatory bowel disease had a fourfold-increased risk for IBD compared with the general population, according to research published in Alimentary Pharmacology & Therapeutics.

A systematic review and meta-analysis revealed a high prevalence of fatigue among patients with inflammatory bowel disease, according to research published in Clinical Gastroenterology and Hepatology.

Short-term anti-tumor necrosis factor treatment combined with surgical closure induced long-term MRI healing in patients with Crohn’s perianal fistulas more frequently than anti-TNF therapy alone, according to research.

BMI, serum transaminase, pre-albumin levels and disease duration may predict the development of nonalcoholic fatty liver disease in patients with Crohn’s disease, according to research published in BMC Gastroenterology.

A comprehensive review of data showed that two doses of a SARS-CoV-2 vaccine were safe and effective in patients with inflammatory bowel disease, according to a report in Alimentary Pharmacology & Therapeutics.

NAPLES, Florida — In this video, Asad Ur Rahman, MD, a gastroenterologist at Cleveland Clinic Florida, spoke with Healio about key takeaways from his 2022 ACG/FGS Spring Symposium presentation on hospitalization in patients with severe IBD.

In this Healio video exclusive, Tara Muzsi, vice president of sales and marketing for gastroenterology at Janssen Pharmaceuticals, discusses the company’s Stelara UnstoppaBOLD 2.0 campaign for patients with inflammatory bowel disease.

NAPLES, Florida — Jennifer L. Seminerio, MD, spoke with Healio about key takeaways from her 2022 ACG/FGS Spring Symposium presentation, which focused on treatment for mild to moderate ulcerative colitis and Crohn’s disease.

Preliminary data from the COMPASS-IBD study showed an interdisciplinary care model improved psychosocial outcome values among patients with inflammatory bowel disease.